Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy
Introduction. Chemotherapy is a common treatment for breast cancer. Chemotherapeutic drugs effect blood monocytes, which are major contributors to cancer pathogenesis. However, to date, pro-tumor or anti-tumor programming by chemotherapy of monocytes is controversial.Aim. To characterize changes in...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-04-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/650 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839573407206735872 |
|---|---|
| author | M. R. Patysheva M. N. Stakheyeva E. S. Grigoryeva P. S. Iamshchikov I. V. Larionova А. A. Budnickya N. A. Tarabanovskaya N. V. Cherdyntseva J. G. Kzhyshkowska |
| author_facet | M. R. Patysheva M. N. Stakheyeva E. S. Grigoryeva P. S. Iamshchikov I. V. Larionova А. A. Budnickya N. A. Tarabanovskaya N. V. Cherdyntseva J. G. Kzhyshkowska |
| author_sort | M. R. Patysheva |
| collection | DOAJ |
| description | Introduction. Chemotherapy is a common treatment for breast cancer. Chemotherapeutic drugs effect blood monocytes, which are major contributors to cancer pathogenesis. However, to date, pro-tumor or anti-tumor programming by chemotherapy of monocytes is controversial.Aim. To characterize changes in phenotypic and transcriptomic profiles of monocytes of breast cancer patients before and after chemotherapeutic treatment.Materials and methods. In a cohort of 50 breast cancer patients, monocyte populations were identified based on their expression of CD14, CD16, CD163, and HLA-DR evaluated by flow cytometry before and after neoadjuvant chemotherapy. Bulk RNA sequencing was adopted to explore the transcriptomic profile of CD14+ monocytes before and after treatment. After treatment, we observed an increase in the activity of signaling pathways related to lipid metabolism and intracellular transport of vesicles from the endoplasmic reticulum, against the background of a decreased response to exposure to interferon γ and interferon α, and foreign molecules (exogenous nucleic acids, viruses and bacteria).Results. In breast cancer patients, neoadjuvant chemotherapy decreased in CD14+16+HLA-DR+ monocytes. Under cytostatic treatment, increased gene expression of MGLL, NR4A2, UCK1, YOD1, ABCA2, PAPSS2, ATP10 (log2FoldChange ≥0.8; false discovery rate (FDR) ≤0.01) and decreased gene expression of KPNA2, ERCC4, JAGN1, RUBCNL, SMYD4, B3GALT4 (log2FoldChange ≥0.8; FDR ≤0.01) were observed in monocytes of patients. Using discriminant analysis, the relative numbers of CD14+16–, CD14+16+, CD14-16+, CD14+16-HLA-DR+, CD14+16+HLA-DR+ and CD14–16+HLA-DR+ monocytes in the blood were found to be valuable in predicting response to neoadjuvant chemotherapy.Conclusion. Thus, association of blood monocytes with chemotherapeutic treatment in breast cancer was revealed. |
| format | Article |
| id | doaj-art-39b45cec6d9b49209bf7f34cbc9bca08 |
| institution | Matheson Library |
| issn | 2313-805X 2413-3787 |
| language | Russian |
| publishDate | 2024-04-01 |
| publisher | ABV-press |
| record_format | Article |
| series | Успехи молекулярной онкологии |
| spelling | doaj-art-39b45cec6d9b49209bf7f34cbc9bca082025-08-04T14:04:37ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872024-04-01111798910.17650/2313-805X-2024-11-1-79-89319Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapyM. R. Patysheva0M. N. Stakheyeva1E. S. Grigoryeva2P. S. Iamshchikov3I. V. Larionova4А. A. Budnickya5N. A. Tarabanovskaya6N. V. Cherdyntseva7J. G. Kzhyshkowska8Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences; National Research Tomsk State UniversityCancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences; National Research Tomsk State UniversityCancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences; National Research Tomsk State UniversityNational Research Tomsk State UniversityCancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of SciencesCancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences; National Research Tomsk State UniversityNational Research Tomsk State UniversityIntroduction. Chemotherapy is a common treatment for breast cancer. Chemotherapeutic drugs effect blood monocytes, which are major contributors to cancer pathogenesis. However, to date, pro-tumor or anti-tumor programming by chemotherapy of monocytes is controversial.Aim. To characterize changes in phenotypic and transcriptomic profiles of monocytes of breast cancer patients before and after chemotherapeutic treatment.Materials and methods. In a cohort of 50 breast cancer patients, monocyte populations were identified based on their expression of CD14, CD16, CD163, and HLA-DR evaluated by flow cytometry before and after neoadjuvant chemotherapy. Bulk RNA sequencing was adopted to explore the transcriptomic profile of CD14+ monocytes before and after treatment. After treatment, we observed an increase in the activity of signaling pathways related to lipid metabolism and intracellular transport of vesicles from the endoplasmic reticulum, against the background of a decreased response to exposure to interferon γ and interferon α, and foreign molecules (exogenous nucleic acids, viruses and bacteria).Results. In breast cancer patients, neoadjuvant chemotherapy decreased in CD14+16+HLA-DR+ monocytes. Under cytostatic treatment, increased gene expression of MGLL, NR4A2, UCK1, YOD1, ABCA2, PAPSS2, ATP10 (log2FoldChange ≥0.8; false discovery rate (FDR) ≤0.01) and decreased gene expression of KPNA2, ERCC4, JAGN1, RUBCNL, SMYD4, B3GALT4 (log2FoldChange ≥0.8; FDR ≤0.01) were observed in monocytes of patients. Using discriminant analysis, the relative numbers of CD14+16–, CD14+16+, CD14-16+, CD14+16-HLA-DR+, CD14+16+HLA-DR+ and CD14–16+HLA-DR+ monocytes in the blood were found to be valuable in predicting response to neoadjuvant chemotherapy.Conclusion. Thus, association of blood monocytes with chemotherapeutic treatment in breast cancer was revealed.https://umo.abvpress.ru/jour/article/view/650monocytesbreast cancerrna-seqtranscriptomechemotherapyhla-dr |
| spellingShingle | M. R. Patysheva M. N. Stakheyeva E. S. Grigoryeva P. S. Iamshchikov I. V. Larionova А. A. Budnickya N. A. Tarabanovskaya N. V. Cherdyntseva J. G. Kzhyshkowska Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy Успехи молекулярной онкологии monocytes breast cancer rna-seq transcriptome chemotherapy hla-dr |
| title | Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy |
| title_full | Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy |
| title_fullStr | Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy |
| title_full_unstemmed | Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy |
| title_short | Immune-phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy |
| title_sort | immune phenotyping and transcriptomic profiling of blood monocytes from patients with breast cancer under neoadjuvant chemotherapy |
| topic | monocytes breast cancer rna-seq transcriptome chemotherapy hla-dr |
| url | https://umo.abvpress.ru/jour/article/view/650 |
| work_keys_str_mv | AT mrpatysheva immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT mnstakheyeva immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT esgrigoryeva immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT psiamshchikov immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT ivlarionova immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT aabudnickya immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT natarabanovskaya immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT nvcherdyntseva immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy AT jgkzhyshkowska immunephenotypingandtranscriptomicprofilingofbloodmonocytesfrompatientswithbreastcancerunderneoadjuvantchemotherapy |